Literature DB >> 17488256

Cytomorphology of hyaline-vascular Castleman's disease: a diagnostic challenge.

M K Mallik1, K Kapila, D K Das, B E Haji, J T Anim.   

Abstract

OBJECTIVE: Hyaline-vascular Castleman's disease (CD) is difficult to diagnose on fine needle aspiration and may be mistaken to be a lymphoreticular malignancy because of the presence of large cells having nuclei showing atypical features. The cytomorphological findings in three histopathologically documented cases of hyaline-vascular CD were evaluated to a set of cytomorphological criteria which could help in the identification of this condition on aspirate smears.
METHODS: The Papanicolaou and Diff-Quik stained smears from three cases of histologically documented hyaline-vascular CD were reviewed by one author. After review the following cytomorphological criteria were suggested to be indicators of the lesion. (i) The presence of large oval to round cells having ill-defined cytoplasmic margins and large nuclei with irregular nuclear outlines having fine or coarse chromatin giving a crumpled tissue paper appearance. (ii) A polymorphous population of lymphoid cells predominantly of small lymphocytes in the background. The smears from these three cases were then mixed with smears from four cases of reactive lymphoid hyperplasia and three cases of Hodgkin's lymphoma. These ten cases were blindly evaluated by two other cytopathologists in order to evaluate the utility of the proposed criteria in identifying CD.
RESULTS: The cytomorphological criteria seen in the methodology section were present in all the cases. These features were helpful in distinguishing CD from reactive lymphoid hyperplasias and Hodgkin's Lymphomas in all cases except one case.
CONCLUSION: Although hyaline-vascular CD is a difficult diagnostic entity on aspirate material the presence of large histiocytic cells with a crumpled tissue paper appearance of the nuclei in a background of small lymphocytes are useful indicators for suspecting this lesion. However, these findings should be analysed in larger studies to determine if they could in anyway reduce the diagnostic dilemma in cases of CD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17488256     DOI: 10.1111/j.1365-2303.2007.00450.x

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  7 in total

Review 1.  A case report of systemic lupus erythematosus combined with Castleman's disease and literature review.

Authors:  Jing-Yan Xia; Xi-Yuan Chen; Feng Xu; Yan Yang; Hui-Ying Wang; Jing Xue
Journal:  Rheumatol Int       Date:  2010-03-31       Impact factor: 2.631

2.  Castleman's disease of a submandibular mass diagnosed on Fine Needle Cytology: Report of a case with histopathological, immunocytochemical and imaging correlations.

Authors:  Maria Gabriella Malzone; Anna Cipolletta Campanile; Veronica Sanna; Franco Ionna; Francesco Longo; Annarosaria De Chiara; Sergio Venanzio Setola; Gerardo Botti; Franco Fulciniti
Journal:  Intractable Rare Dis Res       Date:  2016-02

Review 3.  Castleman's disease--a two compartment model of HHV8 infection.

Authors:  Klaus-Martin Schulte; Nadia Talat
Journal:  Nat Rev Clin Oncol       Date:  2010-07-06       Impact factor: 66.675

4.  Cytologic picture of Castleman's disease: A report of two cases.

Authors:  Ayyagari Sudha; Namala Vivekanand
Journal:  J Cytol       Date:  2010-10       Impact factor: 1.000

Review 5.  A Cytological Review of Follicular Dendritic Cell-Derived Tumors with Emphasis on Follicular Dendritic Cell Sarcoma and Unicentric Castleman Disease.

Authors:  José A Jiménez-Heffernan; Cristina Díaz Del Arco; Magdalena Adrados
Journal:  Diagnostics (Basel)       Date:  2022-02-04

6.  Cytological diagnosis of Castleman's disease of the soft tissue.

Authors:  Manmeet Kaur Gill; Vijay Suri; Vijay K Dubey; Manisha Makkar
Journal:  J Cytol       Date:  2013-07       Impact factor: 1.000

7.  Clinicopathological characteristics of unicentric retroperitoneal Castleman's disease: a study of 14 cases.

Authors:  Shuai Wang; Shanwen Chen; Jiangfeng Xu; Songliang Cai
Journal:  World J Surg Oncol       Date:  2016-01-06       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.